ArticleCanadian respiratory journal2025
HO-1-Enriched Lung-Derived Exosomes Mediate Cognitive Impairment in a Mice Model of COPD Exacerbation.
Article in Canadian respiratory journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to elucidate the impact of HO-1 on cognitive function in chronic obstructive pulmonary disease (COPD) exacerbation mice and uncover the bridging role of exosomes in the interorgan transport of HO-1 along the "lung-brain" axis, providing novel insights into COPD-associated cognitive dysfunction. Methods: HO-1(-/-) and wild-type mice were subjected to COPD exacerbation modeling through cigarette smoke and LPS exposure. Four groups were divided: (A) HO-1(+/+) mice; (B) HO-1(+/+) COPD exacerbation mice; (C) HO-1(-/-) mice; and (D) HO-1(-/-) COPD exacerbation mice. Cognitive function was assessed using the Morris water maze. Lung-derived exosomal HO-1 was quantified by Western blot. Fluorescently labeled exosomes from Groups A/B were injected into HO-1(-/-) mice via tail vein, generating four new cohorts: Group I: HO-1(+/+) mice injected with PBS; Group II: HO-1(-/-) mice injected with PBS; Group III: HO-1(-/-) mice injected with exosome (Exos) from Group A; Group IV: HO-1(-/-) mice injected with Exos from Group B; Exos biodistribution was tracked via in vivo imaging, followed by cognitive reassessment and HO-1 quantification. Results: Groups B/D showed reduced target quadrant dwell time versus Groups A/C, and Group B exhibited longer target quadrant dwell time than Group D. This shows that COPD exacerbation mice had cognitive decline, which was exacerbated by HO-1 deficiency. Group B exhibited higher HO-1 expression in lung exosomes than Group A. Injected exosomes accumulated preferentially in lungs over brain; Group IV displayed worse cognitive impairment than Group III. Conclusions: COPD exacerbation mice exhibit cognitive decline regardless of HO-1 expression status, but HO-1 knockout COPD exacerbation mice demonstrate more pronounced cognitive impairment. In COPD exacerbation mice, HO-1 expression is elevated in lung-derived exosomes. Cross-organ transduction experiments confirm that HO-1 can be transported via Exos and mediate cognitive dysfunction in COPD exacerbation mice. Thus, HO-1 exerts a concentration-dependent dual effect on brain function: protective at physiological levels yet detrimental when in excess.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.